Brain tumors manifest as abnormal growths within the brain or its surrounding structures, potentially arising from diverse cell types like glial cells, neurons, or meninges. These growths can be categorized as either benign or malignant, with the latter having the capacity to infiltrate neighboring tissues and metastasize. Symptoms vary widely based on factors such as tumor size, location, and growth rate. Common manifestations encompass persistent headaches, seizures, alterations in vision or hearing, cognitive decline, and shifts in personality. Diagnosis typically entails a blend of imaging modalities like magnetic resonance imaging (MRI) or computed tomography (CT) scans, followed by biopsy for precise classification and grading. Treatment strategies hinge on variables such as tumor location, size, grade, and patient health status and preferences. Options may encompass surgical excision, radiation therapy, chemotherapy, targeted drug therapy, or a combination thereof. Supportive measures, including steroid administration or anticonvulsants, are sometimes employed to alleviate symptoms and enhance quality of life.
Title : Novel important cellular responses, signaling mechanisms and therapeutic options in vascular dementia
Yong Xiao Wang, Albany Medical College, United States
Title : TBI updates in 2025
Jonathan Eskenazi, Cedars Sinai / UCLA, United States
Title : A case of vile vindictive primary CNS vasculitis
George Diaz, Memorial Healthcare Systems, United States
Title : Non-pharmacological strategies to counteract oxaliplatin toxicity: Protective effects of vagal nerve stimulation and resistance training on neuropathy, motor dysfunction, and muscle atrophy
Ricardo Aparecido Baptista Nucci, Hospital Sirio-Libanes, Brazil
Title : Synapticare: Integrating sleep data and tau biomarkers to assess depression severity
Medha Menon, John Foster Dulles HS, United States
Title : How have we eliminated infection: From the bone to brain?
Thomas J Webster, Interstellar Therapeutics, United States